Human pregnane X receptor compromises the function of p53 and promotes malignant transformation
| Autor: | Delira Robbins, Milu T. Cherian, Jing Wu, Taosheng Chen |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
Cancer Research Pregnane X receptor Cell cycle checkpoint DNA repair DNA damage Immunology Cell Biology Biology digestive system Article digestive system diseases Malignant transformation 03 medical and health sciences Cellular and Molecular Neuroscience Transactivation 030104 developmental biology Nuclear receptor Downregulation and upregulation Cancer research |
| Zdroj: | Cell Death Discovery |
| ISSN: | 2058-7716 |
| DOI: | 10.1038/cddiscovery.2016.23 |
| Popis: | The pregnane X receptor (PXR) is well established as a nuclear receptor that has a central role in xenobiotic metabolism and disposition. However, emerging evidence suggests that PXR is also a regulator of apoptosis, promoting a malignant phenotype both in vitro and in vivo. The tumor suppressor p53 can be activated in the presence of DNA damage and induce cell cycle arrest to allow for DNA repair or, ultimately, apoptosis to suppress tumor formation. We previously identified p53 as a novel PXR-associated protein by using a mass spectrometric approach. In the current study, we identified a novel inhibitory effect of PXR on p53, revealing an anti-apoptotic function of PXR in colon carcinogenesis. PXR expression reduced p53 transactivation and the expression of its downstream target genes involved in cell cycle arrest and apoptosis by decreasing p53 recruitment to the promoter regions of these genes. Consistent with the inhibitory effect of PXR on p53, elevated PXR levels decreased doxorubicin- or nutlin-3a-mediated toxicity and promoted malignant transformation in colon cancer cells. Our findings show for the first time that PXR expression modulates p53 target gene promoter binding and contributes to the downregulation of p53 function in human colon cancer cells. These results define the functional significance of PXR expression in modulating p53-mediated mechanisms of tumor suppression. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|